Novelix Pharmaceuticals Limited (NOVELIX)
Market Closed
11 Aug, 22:00
MSE MSE Primary ₹
76. 50
+3.15
+4.2945%
₹
1.14B Market Cap
- P/E Ratio
- Div Yield
2,132 Volume
- Eps
₹ 73.35
Previous Close Want to track NOVELIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novelix Pharmaceuticals Limited (NOVELIX) Statistics
Valuation metrics
Market Cap 1.14B
Enterprise value 907.64M
Trailing P/E (ttm) 47.11
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) 0.88
Price/Book (mrq) 2.99
Enterprise Value/Revenue 0.71
Enterprise Value/EBITDA 37.46
Overview
Shares outstanding 21.09M
Float 3.72M
Shares short -
% Held by insiders 0.76%
% Held by institutions -
Average volume (10 days) 4.62K
Average volume (90 days) 6.06K
Price summary
52-Week low 38
52-Week high 92
Beta 0.37
50-Day moving average 55.04
200-Day moving average 52.24
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.01%
Operating margin 0.03%
Operational effectiveness
Return on assets 0%
Return on equity 0%
Income Statement
Revenue (ttm) 1.28B
Revenue per share (ttm) 84.95
Quarterly revenue growth (yoy) 8.13%
Gross profit (ttm) 38.93M
EBITDA 24.65M
Net income to common (ttm) 18.06M
Diluted EPS (ttm) 1.13
Quarterly earnings growth (yoy) 5.79%
Balance Sheet
Total cash (mrq) 14.5M
Total cash per share (mrq) 0.84
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.53%
Book value per share (mrq) 17.77
Cash Flow
Cash flow statement -221.35M
Levered free cash flow (LFCF) 845.2K
